Predicting lupus disease activity with blood tests
Part of Immune system & allergy clinical trials.
This study looks at whether two blood markers (AGR and PNI) can help track how active lupus is. You may be eligible if you have lupus and are not pregnant or have other serious health conditions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with systemic lupus erythematosus (SLE).
- You are not pregnant or breastfeeding.
- You do not have another autoimmune disease or chronic infection.
- You have not had a serious infection in the past month.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at a simple blood test (called the Systemic Immune Inflammatory Index) to see if it can help doctors understand how active lupus is in your body. It includes people with lupus, especially those with kidney involvement, to find better ways to track the disease.
This study looks at two blood markers (IgG and IgM) in people with lupus to see if they can help measure disease activity and damage. It may help doctors better understand and manage lupus.
This study looks at a protein called CXCL5 in the blood of people with lupus (SLE) to see if it relates to how active their disease is. It will help researchers understand more about lupus and possibly find new ways to track or treat it.
This study tests a simple, needle-free method to check for early heart and blood vessel disease in people with lupus nephritis (kidney inflammation from lupus). It uses a formula based on your blood sugar and fat levels to see if you are at higher risk, without needing special scans.
This study looks at whether certain blood test ratios (albumin/globulin and platelet/albumin) can help identify or predict lupus nephritis, a kidney problem caused by lupus. It may help doctors better understand and manage kidney involvement in lupus patients.
This study looks at blood and urine markers that may show how active lupus kidney disease is and how it changes over time. It may help doctors better monitor people with active lupus-related kidney inflammation.
Hear when a new Systemic Lupus Erythematosus Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.